BELNUC General Assembly and Seminar: February 24th, 2024

Published on: December 6, 2023

Save the date for the next annual BELNUC General Assembly and Seminar: 24/02/2024 at the KUL campus (9:00 – 12:30).

  • Venue: KUL Leuven, Code Parking 7655#, auditorium GA1 located at Onderwijs & Navorsing 1.

Click here to register!

The annual BELNUC General Assembly and Seminar is kindly supported by Von Gahlen.

Von Gahlen is a state-of-the-art manufacturer of shielding solutions for nuclear medicine and radiopharmacy. We offer standard and custom-built hot cells along with a wide range of auxiliary equipment for hot labs. With Von Gahlen you can be assured of safe solutions, a reliable partnership, and a lasting relationship.

Seminar topic: PET in hematological Malignancies:

The last fifteen years have been marked by the harmonization of interim and end-of-treatment PET/CT interpretation criteria in lymphoma (Deauville scale 2009).

Nowadays, the implementation of PET/CT guided therapeutic strategies and  the development of new prognostic biomarkers on baseline PET/CT, such as total metabolic tumor volume and tumor dissemination metrics are necessary.

It is time to propose standardized measurements of metabolic tumor burden to prepare for risk adaptation in lymphoma.

Likewise, the implications of PET imaging in multiple myeloma for treatment and response assessment will also be detailed.



Moderators: Dr Anne Delcourt  Mouscron and Pr Olivier Gheysens UCL Bruxelles

09:00-09:45      Marie Vercruyssen – Hematology HUB

                        “Lymphoma and Multiple Myeloma in 2024: PET guided management and new treatments”

09:45-10:30      Pr. Andrea Gallamini – from Nice. 

                        “New metrics of PET scan reading in lymphoma”

10:30-11:00      Break

11:00-11:30      Pr. Nadia Withofs – CHU Liège.

                        “Guideline on the use of  PET/CT in Multiple Myeloma”

11:30-12:30      General assembly

  • RIZIV/INAMI has granted 2 credits (Category 3, N°23032711) – RIZIV/INAMI accreditation for nuclear medicine physicians is available for BELNUC members only.
  • FANC/AFCN has granted: 2h pour les médecins nucléaristes, 2h pour les personnes habilitées en médecine nucléair, 2h pour les radiophysiciens en médecine nucléair, 2h pour les radiopharmaciens